HIV volunteers pause meds to unlock virus secrets
NCT ID NCT04359186
First seen Jan 30, 2026 · Last updated May 14, 2026 · Updated 14 times
Summary
This study pauses HIV medication in 40 volunteers to closely watch how the virus and body interact early on. Participants stop their antiretroviral therapy for up to three weeks and have frequent check-ups. Most will restart treatment within three weeks, even if the virus stays undetectable. The goal is to learn more about HIV, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California San Francisco
RECRUITINGSan Francisco, California, 94110, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.